Clinical Trials Directory

Trials / Completed

CompletedNCT04826848

Lactate Clearance in Hospital-acquired Pneumonia

The Prognostic Value of Lactate Clearance in Hospital-acquired Pneumonia

Status
Completed
Phase
Study type
Observational
Enrollment
69 (actual)
Sponsor
Ankara City Hospital Bilkent · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There is no clear consensus on the use of pneumonia severity index (PSI) developed for community-acquired pneumonia in hospital-acquired pneumonia cases. In another aspect, PSI is a relatively difficult scoring system that includes many parameters. This study evaluated whether lactate clearance could be used as a mortality marker instead of PSI in hospital-acquired pneumonia. As a result, lactate clearance was lower in the mortal group and when the diagnostic statistics were evaluated, it was seen that the sensitivity and specificity rates were significantly higher. In conclusion, lactate clearance has been evaluated as a strong predictor of mortality in hospital-acquired pneumonia.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLactateWe will evauate the lactate clearance of the patients in 6 hours period. Lactate clearance = \[(Initial lactate - 6th hour lactate) / Initial lactate\] \* 100

Timeline

Start date
2019-06-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2021-04-01
Last updated
2021-05-26

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04826848. Inclusion in this directory is not an endorsement.